Hosted on MSN1mon
H.C. Wainwright maintains $25 target on Milestone sharesO n Monday, H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and a price target of $25.00 on Milestone Pharmaceuticals, traded on NASDAQ under the ticker (NASDAQ:MIST). The stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback